EUVIMEDScopri EUVIMED
Evaluationsstudie

Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants

Xiaoyi Liu iD, Xianzhen Cao iD, Liang Hu iD, Yanan Liu iD, Shuxian Zeng iD, Weiqiang Liu iD, Fengxiang Wei iD

Prenatal Diagnosis · 2026

DOI: 10.1002/pd.70262 ↗

At a glance

Evaluationsstudie in Prenatal Diagnosis, 2026. Written by Xiaoyi Liu and 6 co-authors. Institution: Central Laboratory, Longgang District Maternity & Child Healthcare Hospital (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou …. Major MEDLINE topics: DNA Copy Number Variations, Cell-Free Nucleic Acids, Noninvasive Prenatal Testing, Prenatal Diagnosis. 36 references. Funded by: Natural Science Foundation of Shenzhen Municipality, Medical and Health Technology Research Project, Special Funds for Science and Technology, Innovation Longgang District of Shenzhen City.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

To evaluate the performance of low‐depth non‐invasive prenatal testing (NIPT) using cell‐free DNA enrichment for detecting fetal copy number variations (CNVs) and to assess its clinical utility.

Methods

A retrospective analysis was conducted on 86,012 pregnant women who underwent NIPT with size‐selective cell‐free DNA enrichment. CNVs were detected using a Hidden Markov Model. Following prenatal diagnosis of positive cases through chromosome microarray analysis (CMA), positive predictive values (PPVs) were evaluated across different CNV sizes and fetal fractions, and the accuracy of CNV breakpoint validation was assessed.

Results

DNA enrichment achieved a mean fetal fraction of 18.88% ± 5.82%. A total of 340 CNVs were detected in 339 pregnant women, with an overall CNV positive rate of 0.39% [95% CI: 0.35%, 0.44%] (339/86, 012), including 249 deletions and 91 duplications. The total PPV for CNVs was 59.20% [95% CI: 52.05%, 66.00%] (119/201). For the accuracy of CNV size and position, 85.83% [95% CI: 78.01%, 91.29%] (103/120) of CNVs had size discrepancies < 25% compared to CMA, and 80.42% [95% CI: 74.71%, 85.13%] (193/240) of breakpoints were within 1 Mb. The 22q11.21 deletion was the most frequent CNV (16.76% [95% CI: 13.04%, 21.26%] (57/340)), with a PPV of 40.00% [95% CI: 25.28%, 56.61%] (16/40).

Conclusion

An elevated fetal fraction improves breakpoint accuracy. In addition to increasing sequencing depth, it represents a promising technical approach to optimizing the performance of NIPT.

Subjects

MeSH terms (MEDLINE)

DNA Copy Number VariationsCell-Free Nucleic AcidsNoninvasive Prenatal TestingPrenatal DiagnosisHumansFemalePregnancyRetrospective StudiesAdultPlacenta

Author keywords

NIPTcopy number variantperformance evaluationpositive predictive valuesprenatal cell‐free DNA screening

Substances

Cell-Free Nucleic Acids

Authors and institutions

  • Central Laboratory, Longgang District Maternity & Child Healthcare Hospital (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
  • Longgang District Key Laboratory for Birth Defects Prevention, Shenzhen, China.
  • GuangDong Engineering Technology Research Center of Genomics and Precision Imaging, Shenzhen, China.

ORCID profiles: Xiaoyi Liu, Xianzhen Cao, Liang Hu, Yanan Liu, Shuxian Zeng, Weiqiang Liu, Fengxiang Wei

Funding

  • Natural Science Foundation of Shenzhen Municipality
  • Medical and Health Technology Research Project, Special Funds for Science and Technology, Innovation Longgang District of Shenzhen City

Cite

APA

Liu, X., Cao, X., Hu, L., Liu, Y., Zeng, S., Liu, W., & Wei, F. (2026). Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants. Prenatal Diagnosis. https://doi.org/10.1002/pd.70262

Vancouver

Liu X, Cao X, Hu L, Liu Y, Zeng S, Liu W, et al. Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants. Prenatal Diagnosis. 2026. doi:10.1002/pd.70262

BibTeX
@article{Liu2026,
  author = {Liu, Xiaoyi and Cao, Xianzhen and Hu, Liang and Liu, Yanan and Zeng, Shuxian and Liu, Weiqiang and Wei, Fengxiang},
  title = {Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70262}
}
Start for free →